Navigation Links
Carreras Foundation to Endow Clinical-Research Chair at Fred Hutchinson Cancer Research Center

Internationally renowned tenor expresses gratitude for successful treatment

SEATTLE, Oct. 16 /PRNewswire/ -- The Friends of Jose Carreras International Leukemia Foundation has announced it will endow a chair for clinical research at Fred Hutchinson Cancer Research Center in honor of E. Donnall Thomas, M.D., who pioneered the bone-marrow transplant.

The Foundation cites a strong wish to honor Carreras and Thomas, emeritus director of clinical research at the Hutchinson Center. Thomas' research in bone-marrow transplantation has saved thousands of lives and won the 1990 Nobel Prize in physiology or medicine.

In 1987, Carreras was diagnosed with acute lymphoblastic leukemia and traveled to the Hutchinson Center for what proved to be a successful series of treatments, including a bone-marrow transplant. In 1988, in deep gratitude to both science and society for the life-saving treatment and the care and affection he received during his illness, Carreras enlisted the help of noted physicians and scientists to initiate the Fundacion Internacional Josep Carreras in his hometown of Barcelona.

"I want to express my deepest admiration for the work of the Fred Hutchinson Cancer Research Center and its dedication toward science, leukemia patients and their families," Carreras said. "The Hutchinson Center and the Foundation share a common goal: to achieve that leukemia becomes one day a totally curable disease, always and for everyone. It is a real pleasure to collaborate with the Fred Hutchinson Cancer Research Center, and especially with an admirable person like Dr. Thomas."

"There are innumerable links that bind me with the Fred Hutchinson Cancer Research Center and with Dr. Thomas. It is an honor and a great responsibility to continuously count on the trust, help and support of the Hutchinson Center and Dr. Thomas," Carreras said.

The Spanish Carreras foundation and branch foundations in the United States, Germany and Switzerland concentrate their efforts in four main areas: funding scientific research, health care infrastructure, promotion of transplantation, and social service to leukemia patients and their families. In addition to funding leukemia research, the Spanish Carreras foundation has worked to establish a bone-marrow registry in Spain. The foundation and its affiliates have helped support dozens of scientists worldwide, including annual fellowships for promising early-career scientists at the Center and throughout the world.

The Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research will be awarded to a full member of the Center's Clinical Research Division who spends at least 75 percent of his/her time in research. Candidates will be nominated by their peers and selected by a committee chaired by the Center's president and director. They must have an international reputation for excellence in their field of research and, in addition, will have independent grant support.

In September, Thomas and Center colleagues celebrated the 50th anniversary of his groundbreaking paper on the promise of human bone-marrow transplantation in the New England Journal of Medicine.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit


Christi Ball Loso

(206) 667-5215

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag Specialties, Inc. (BSI) ... for the Nutraceutical Specialties products into oral solid dosage in the over the ... “We are pleased to announce our expanded distribution agreement with ASI.” said Steve ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., is ... "My last baby had high blood pressure due to loud noises," she said, "so ... babies from noise pollution as well as radio waves and microwaves." , The baby ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The ... and technical experience available within DataTrade to extend the services currently provided by ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Nuance Communications, Inc. ... National Decision Support Company (NDSC) today jointly announced ... collaboration capabilities that utilize the American College of Radiology,s ... provider organizations to comply with current and emerging ... --> By combining clinical decision support, ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate the ... 57 th American Society of Hematology (ASH) Annual ... myelomas as well as supportive care, including key findings ... personalized cell therapies. The ASH Annual Meeting will be ... . Novartis Oncology . "We will be ...
(Date:11/30/2015)... Israel , Nov. 30, 2015  OticPharma, Ltd., ... and developing innovative therapies for ear, nose, and throat ... A. Katkin as chairman of the company,s board ... executive officer for OticPharma, Ltd.  "Keith brings a wealth ... will be able to share this experience and provide ...
Breaking Medicine Technology: